Vascular Endothelial Growth Factor (VEGF)-A165-induced Prostacyclin Synthesis Requires the Activation of VEGF Receptor-1 and -2 Heterodimer

This publication has 45 references indexed in Scilit:

• Simvastatin potenciates PGI2 release induced by HDL in human VSMC: effect on Cox-2 up-regulation and MAPK signalling pathways activated by HDL
  Atherosclerosis, 2004
• HDL ₃ Induces Cyclooxygenase-2 Expression and Prostacyclin Release in Human Endothelial Cells Via a p38 MAPK/CRE-Dependent Pathway: Effects on COX-2/PGI-Synthase Coupling
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2004
• Mechanisms involved in the stimulation of prostacyclin synthesis by human lymphocytes in human umbilical vein endothelial cells
  British Journal of Pharmacology, 2003
• Role of cyclooxygenase 2, p38 and p42/44 MAPK in the secretion of prostacyclin induced by epidermal growth factor, endothelin-1 and angiotensin II in rat ventricular cardiomyocytes
  Journal of Molecular and Cellular Cardiology, 2003
• Relative effects of VEGF‐A and VEGF‐C on endothelial cell proliferation, migration and PAF synthesis: Role of neuropilin‐1
  Journal of Cellular Biochemistry, 2002
• Receptor Chimeras Indicate That the Vascular Endothelial Growth Factor Receptor-1 (VEGFR-1) Modulates Mitogenic Activity of VEGFR-2 in Endothelial Cells
  Journal of Biological Chemistry, 2000
• SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1
  Published by Wiley ,2000
• The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities
  Journal of Biological Chemistry, 1996
• Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages
  Biochemical and Biophysical Research Communications, 1991
• Angiogenic Factors
  Science, 1987